Skip to main content
CSL Ltd. logo

CSL Ltd. — Investor Relations & Filings

Ticker · CSL ISIN · AU000000CSL8 LEI · 529900ECSECK5ZDQTE14 ASX Manufacturing
Filings indexed 2,545 across all filing types
Latest filing 2025-08-18 Regulatory Filings
Country AU Australia
Listing ASX CSL

About CSL Ltd.

https://www.csl.com/

CSL is a global biotechnology company that researches, develops, manufactures, and markets a diverse portfolio of medicines. The company operates through distinct business units. CSL Behring provides plasma-derived and recombinant biotherapies for patients with rare and serious diseases, including bleeding disorders, immunodeficiencies, and neurological disorders. CSL Seqirus is a leading provider of vaccines, with a focus on influenza prevention and public health. CSL Vifor specializes in therapies for iron deficiency and nephrology, addressing the full spectrum of kidney disease. Collectively, CSL delivers lifesaving and life-enhancing treatments to a global patient population.

Recent filings

Filing Released Lang Actions
CSL Results Presentation 32 pages 3.0MB
Regulatory Filings
2025-08-18 English
Appendix 4G and Corporate Governance Statement 34 pages 4.5MB
Regulatory Filings
2025-08-18 English
Notice of Investor/Analyst Briefing 2025 Full Year Result 1
Regulatory Filings
2025-08-17 English
Notification of cessation of securities - CSL 4 pages 14.6KB
Regulatory Filings
2025-08-04 English
Notification of cessation of securities - CSL 4 pages 14.6KB
Regulatory Filings
2025-07-06 English
CSL's Andembry FDA Approved 2 pages 138.3KB
Regulatory Filings
2025-06-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.